Search

everythinglearnresearchcommunity

for

Search:↓

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Adipose-derived stem cells help heal radiation skin damage by reducing cell death and inflammation.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Necrobiosis lipoidica may need new criteria for accurate diagnosis due to similarities with another condition.

Psoriasis is a common skin disorder caused by immune system issues, treatable with various therapies.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

ADSCs help protect skin from UV damage and aging.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

StemMACS media is better for growing therapeutic stem cells than PowerStem media.

Familial dyskeratotic comedones are a rare, benign skin disorder that is hard to treat.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.